Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells

Jul 22, 2016Cancer immunology, immunotherapy : CII

Glioblastoma cells resist killing and keep releasing inflammatory signals despite lower immune activation after attack by natural killer cells

AI simplified

Abstract

Natural killer (NK) cells showed decreased ability to kill brain cancer stem-like cells, leading to potential tumor growth inadequacy.

  • Brain cancer stem-like cells and poorly differentiated glioblastoma multiforme showed increased resistance to NK cell lysis when differentiated by split anergized NK supernatants.
  • Differentiation of these cells was associated with higher expression of CD54, B7H1, and MHC-I.
  • The resistance to NK cells and the differentiation of brain cancer stem-like cells were mediated by interferon (IFN)-γ and tumor necrosis factor (TNF)-α.
  • These brain cancer cells expressed low levels of tumor necrosis factor receptors and IFN-γ receptors.
  • Increased secretion of interleukin (IL)-6 and chemokine IL-8 was observed in the presence of decreased IFN-γ secretion during NK cell interaction.
  • NK-induced differentiation of brain cancer stem-like cells was independent of the functions of IL-6 and IL-8.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free